Adjuvant therapy with somatostatin analogs for recurrent gastric neuroendocrine tumors type 1

被引：0
|
作者：
Markovich, Alla Anatolievna
Zhulikov, Yaroslav
Evdokimova, Ekaterina
Gorbunova, Vera
Emelianova, Galina
Gadzhieva, Kizler
Malikhova, Olga
Karasev, Ivan
Delektorskaya, Vera
Kuvshinov, Yuri
Kuznetsova, Anna
Artamonova, Elena
机构：
[1] Samsung Res Ctr Russia, Moscow, Russia
[2] Minist Hlth Russian Federat, NN Blokhin Natl Med Res Ctr Oncol, Fed State Budgetary Inst, Moscow, Russia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.665
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：665 / 665
页数：1
相关论文
共 50 条
  • [41] Recurrent gastric neuroendocrine tumors treated with total gastrectomy
    Jung, Myounghwa
    Kim, Jung-Wook
    Jang, Jae-Young
    Chang, Young Woon
    Park, Sun Hee
    Kim, Yong Ho
    Kim, Youn Wha
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (46) : 13195 - 13200
  • [42] ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogs
    Kwekkeboom, Dik J.
    Krenning, Eric P.
    Lebtahi, Rachida
    Komminoth, Paul
    Kos-Kudla, Beata
    de Herder, Wouter W.
    Ploeckinger, Ursula
    NEUROENDOCRINOLOGY, 2009, 90 (02) : 220 - 226
  • [43] Role of somatostatin analogs in the clinical management of non-neuroendocrine solid tumors
    Kvols, Larry K.
    Woltering, Eugene A.
    ANTI-CANCER DRUGS, 2006, 17 (06) : 601 - 608
  • [44] Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system
    Öberg, K
    Kvols, L
    Caplin, M
    Delle Fave, G
    de Herder, W
    Rindi, G
    Ruszniewski, P
    Woltering, EA
    Wiedenmann, B
    ANNALS OF ONCOLOGY, 2004, 15 (06) : 966 - 973
  • [45] Safety review: Dose optimization of somatostatin analogs in patients with acromegaly and neuroendocrine tumors
    William H. Ludlam
    Lowell Anthony
    Advances in Therapy, 2011, 28 : 825 - 841
  • [46] TREATMENT WITH SOMATOSTATIN ANALOGS OF RECURRENT TYPE I GASTRIC CARCINOID IN PATIENTS WITH AUTOIMMUNE CHRONIC ATROPHIC GASTRITIS
    Massironi, S.
    Spampatti, M. P.
    Rossi, R. E.
    Zilli, A.
    Ciafardini, C.
    Conte, D.
    Peracchi, M.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : S88 - S88
  • [47] The Drawback to Treat Neuroendocrine Bronchial Tumors with High Doses of Radiolabelled Somatostatin Analogs
    Limouris, G. S.
    Karfis, I.
    Paphiti, M. I.
    McCready, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S457 - S457
  • [48] Induction of apoptosis in neuroendocrine tumors of the digestive system during treatment with somatostatin analogs
    Imam, H
    Eriksson, B
    Lukinius, A
    Janson, ET
    Lindgren, PG
    Wilander, E
    Oberg, K
    ACTA ONCOLOGICA, 1997, 36 (06) : 607 - 614
  • [49] Safety Review: Dose Optimization of Somatostatin Analogs in Patients with Acromegaly and Neuroendocrine Tumors
    Ludlam, William H.
    Anthony, Lowell
    ADVANCES IN THERAPY, 2011, 28 (10) : 825 - 841
  • [50] Treatment with Somatostatin Analogs of Recurrent Type I Gastric Carcinoid in Patients with Autoimmune Chronic Atrophic Gastritis
    Massironi, S.
    Zilli, A.
    Rossi, R. E.
    Fanetti, I.
    Ciafardini, C.
    Conte, D.
    Peracchi, M.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 241 - 241
12345